Oncosure Testing
Healthcare Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1550 N Andrews Avenue Ext, Pompano Beach...Phone Number
(754) 290-3579Website
patients.oncosuretesting.comRevenue
<$5 MillionIndustry
About Oncosure Testing
Oncosure Testing Org Chart
Is Oncosure Testing your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Oncosure Testing
Funding: Get notified immidiatlly once Oncosure Testing has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Oncosure Testing, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Oncosure Testing has recently received funding, and reach out quickly before it becomes old news!
Check out if Oncosure Testing is spiking on competitors!
Earning: See what the market has to say on Oncosure Testing recently announced quarterly report
Click to see if Oncosure Testing had a recent Job posting/layoffs
Product Launch: Get notified when Oncosure Testing launches new products
Recommended Actions
Find VP level buyers at Oncosure Testing
Find more new buyers
Company Profile Activity
Activity Insights
Oncosure Testing is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Oncosure Testing is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Oncosure Testing.
Top Healthcare Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Oncosure Testing
Oncosure Testing provides innovative early cancer detection services through a simple blood draw that identifies traces of all human cancers within 24 hours. The company focuses on non-invasive, affordable, and accurate cancer screenings, achieving 97.06% accuracy across all stages of cancer. Utilizing advanced technology and expert leadership, Onc... Read More